Article Text
Statistics from Altmetric.com
- evidence-based medicine
- health care economics and organizations
- organization and administration
- public health
- pharmacy service
- hospital
In the field of medical devices, innovation has been debated to a much less extent when compared with pharmaceutical products. In Italy, the regulation of innovative pharmaceutical products was established in 2017, through a resolution1 issued by the national medicines agency (AIFA) after the adoption of a national law.2 According to this regulation, innovative medicines (reported in a national list3) are made immediately available to patients, even without formal inclusion in the regional hospital therapeutic schedules.
As regards medical devices, a first attempt to issue a regulation on innovative devices has been made at the regional level in the Tuscany region. A multidisciplinary group of healthcare professionals (eight members of the so-called ‘Gruppo Regionale permanente sui dispositivi …
Footnotes
Contributors The four authors contributed equally to this letter.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.